Medication Safety Officers Society
4039 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations
I am new to the medication safety position, and I would like to update the job description of the medication safety officer in my institution. I would appreciate if anyone could share his/her job description? it will be very helpful to have insight on different aspects.
We have pharmacists in all of our emergency departments for all except a few hours overnight. We currently verify all ED medication orders prior to administration (with the exception of true emergencies such as codes). We do not generally have problems with turnaround times and typically verify all orders within 5 minutes.
Hello everyone! I was wondering if anyone in this group happened to already research the safety mechanisms of available enoxaparin prefilled syringe products. Appreciate any insight anyone may have on this topic.
Looking for information specifically to Post-Partum oxytocin infusion.
We have smart pump library for this drug/indication (soft max 333 mL/hr), but are getting push back because the drug needs to be run in as faster than 999 mL/hr therefore they run it by gravity and with a pressure bag. There concerns with using the pump are due to extravasation, infiltration.
Would anyone at facilities that perform cardiac bypass surgeries be willing to share how KCl vials are provided for perfusionists? Are they made available via ADM, in kits? Are they handled as a controlled substance?
Has anyone reviewed their oral solutions labeling in the MAR and revised them? Ours are inconsistent and some list the strength per 5 mL, strength per single mL, no concentration at all, etc. Of note, this is referring specifically to MAR name for a patient-specific order, not referring to the actual label on the cup or the patient-specific label attached to the cup.
Good morning! Would anyone be willing to share what objective, quantifiable criteria your organization has set for patient safety in the employee annual evaluations? We are trying to move away from a set threshold of monthly submissions to our voluntary reporting system. We have 1 inpatient pharmacy, 5 outpatient pharmacies, and a clinical pharmacist staff (inpatient/ambulatory clinics) that we would like to *hopefully* apply the same criteria to.
For those organizations that participate in Leapfrog, what are you doing to ensure workarounds with BCMA are not occurring? The manual references real-time observations and says that structures should be in place to monitor and reduce workarounds, but doesn't give anything beyond that.